ISSN: 2332-0877

Jornal de doenças infecciosas e terapia

Acesso livre

Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Omics Technologies: A Hope for Translational Research in Bovine Tuberculosis

Gloria Guillermina Guerrero

Bovine tuberculosis diagnosis is one of the main challenges faced by animal and public health systems. The incidence of M. bovis infections remains undefined in developed countries. So it is necessary to carry out an extensive study and surveillance to determine the status of bovine tuberculosis as an urgent need for control eradication program. Furthermore, developed countries, microbiological (bacteriological) and immunological (histochemistry) techniques are still used, making more difficult to homogenize epidemiological knowledge of bTB. Recent reports describing the potential of microarray technology not only to explore subunit vaccine agents (biomarkers), but to pinpoint immunomodulation, and signatures in the journey of pathogen interaction with the host in bovine tuberculosis. Omics and next generation high-throughput technologies have risen as promising tools that will enable translational research (development of prognostic and diagnostic methods with high accuracy and sensibility) and in depth molecular analysis even at single cell level to underpin dynamics in the transcripts regulation of the host response in bTB.